The Washington Post is reporting Johnson & Johnson plans to ask doctors to return its power morcellators, a surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.
The company’s Ethicon unit in April suspended sales and distribution of the devices while their role in treating symptomatic fibroid disease is reviewed by the Food and Drug Administration and the medical community. The FDA had advised doctors not to use the devices, pending further review.
The U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.
Laparoscopic power morcellation is one of several available treatments for fibroids. It is a procedure that uses a medical device to divide the uterine tissue into smaller pieces or fragments so it can be removed through a small incision in the abdomen, such as during laparoscopy.
If you or a loved one have had Laparoscopic power morcellation and have been diagnosed with cancer, call us now at (800) 888-8888 or contact us online.